000 | 01137 a2200325 4500 | ||
---|---|---|---|
005 | 20250517171740.0 | ||
264 | 0 | _c20171016 | |
008 | 201710s 0 0 eng d | ||
022 | _a1600-0447 | ||
024 | 7 |
_a10.1111/acps.12795 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEbdrup, B H | |
245 | 0 | 0 |
_a'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response. _h[electronic resource] |
260 |
_bActa psychiatrica Scandinavica _c11 2017 |
||
300 |
_a526-527 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
650 | 0 | 4 | _aAntipsychotic Agents |
650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aObesity |
650 | 0 | 4 | _aSchizophrenia |
700 | 1 | _aIshøy, P L | |
700 | 1 | _aFagerlund, B | |
700 | 1 | _aBroberg, B V | |
700 | 1 | _aBak, N | |
700 | 1 | _aKnop, F K | |
700 | 1 | _aGlenthøj, B Y | |
773 | 0 |
_tActa psychiatrica Scandinavica _gvol. 136 _gno. 5 _gp. 526-527 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/acps.12795 _zAvailable from publisher's website |
999 |
_c27503435 _d27503435 |